Westwood Holdings Group Inc Gilead Sciences, Inc. Transaction History

Westwood Holdings Group Inc

$12.8 Billion
Q1 2024

A detailed history of Westwood Holdings Group Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Westwood Holdings Group Inc holds 456,712 shares of GILD stock, worth $31.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

456,712

Previous 456,712 -0.0%

Holding current value

$31.3 Million

Previous $33.5 Million -0.0%

% of portfolio

0.26%

Previous 0.26%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $59.7 Million - $72.8 Million	-834,552 Reduced 64.63%	456,712 $33.5 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $2.81 Million - $3.19 Million	-38,338 Reduced 2.88%	1,291,264 $105 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $2.74 Million - $2.99 Million	-37,108 Reduced 2.72%	1,329,602 $99.6 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $27.3 Million - $31.1 Million	-358,546 Reduced 20.78%	1,366,710 $105 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $18.9 Million - $21.5 Million	244,025 Added 16.47%	1,725,256 $143 Million

Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $6.9 Million - $9.9 Million	-110,659 Reduced 6.95%	1,481,231 $127 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $2.21 Million - $2.53 Million	-37,133 Reduced 2.28%	1,591,890 $98.2 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $6.15 Million - $6.93 Million	-106,617 Reduced 6.14%	1,629,023 $101 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $16.3 Million - $20.4 Million	280,942 Added 19.31%	1,735,640 $103 Million
Q4 2021 Feb 25, 2022	BUY	$64.88 - $73.64 $7.43 Million - $8.43 Million	114,470 Added 8.54%	1,454,698 $106 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $65.8 Million - $70.9 Million	971,413 Added 263.39%	1,340,228 $93.6 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $4.22 Million - $4.61 Million	66,428 Added 21.97%	368,815 $25.4 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $1.45 Million - $1.65 Million	24,152 Added 8.68%	302,387 $19.5 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $3.2 Million - $3.65 Million	-56,505 Reduced 16.88%	278,235 $16.2 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $10.4 Million - $13.1 Million	-167,899 Reduced 33.4%	334,740 $21.2 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $1.77 Million - $2.06 Million	24,493 Added 5.12%	502,639 $38.7 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $29.9 Million - $38.4 Million	478,146 New	478,146 $35.7 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $413,191 - $456,090	-6,610 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $408,960 - $458,601	6,610 New	6,610 $447,000

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.

Account

Westwood Holdings Group Inc Gilead Sciences, Inc. Transaction History